SCHEMBL7534095

SCHEMBL7534095

Cc1nc2c3c(cccc3n1)C(=O)c1ccccc1-2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.58
KMT2A Q03164 5/20 0.58
MEN1 O00255 4/20 0.58
APEX1 P27695 2/20 0.58
RAB9A P51151 6/20 0.49
MAPK1 P28482 2/20 0.49
MAOA P21397 1/20 0.49
NPC1 O15118 5/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
ALDH1A1 P00352 4/20 0.49
AHR P35869 1/20 0.49
EIF2AK2 P19525 2/20 0.46
MAPK12 P53778 2/20 0.46
MAPK13 O15264 1/20 0.46
MAPK11 Q15759 1/20 0.46
MAPK14 Q16539 1/20 0.46
PABPC1 P11940 4/20 0.46
KDM4E B2RXH2 3/20 0.46
CYP3A4 P08684 2/20 0.46
CASP1 P29466 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19792777 0.86 MAPT (0.44) MAPTKMT2AMEN1APEX1RAB9A
SCHEMBL20256150 0.80 MAPT (0.50) MAPTKMT2AMEN1APEX1RAB9A
SCHEMBL19162426 0.80 MAPT (0.50) MAPTKMT2AMEN1APEX1RAB9A
SCHEMBL7535432 0.78 MAPT (0.48) MAPTKMT2AMEN1APEX1RAB9A
SCHEMBL23946310 0.75 KCNH2 (0.51) MAPTKMT2AMEN1APEX1SMN1; SMN2
SCHEMBL460367 0.72 MAOA (0.56) MAPTKMT2AMEN1APEX1RAB9A
SCHEMBL23946340 0.72 KCNH2 (0.46) MAPTKMT2AMEN1APEX1SMN1; SMN2
SCHEMBL23946292 0.72 KCNH2 (0.49) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL19046675 0.72 KDM4E (0.49) MAPTKMT2AMEN1APEX1RAB9A
SCHEMBL19046669 0.72 KDM4E (0.47) MAPTKMT2AMEN1APEX1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10347845-B2 Nitrogen-containing condensed cyclic compound and organic light emitting device using same LG CHEM, LTD. (KR) 2019-07-09 US disclosed
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2017-07-27 US disclosed
WO-2002030906-A1 ANTI-TUMOUR COMPOUNDS LA TROBE UNIVERSITY (AU) 2002-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10347845-B2 Nitrogen-containing condensed cyclic compound and organic light emitting device using same CRY1, NOS1, NOLC1 MAPT 1589/4885KMT2A 1423/4885MEN1 197/4885
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, NOS1, NOLC1 MAPT 1589/4885KMT2A 1423/4885MEN1 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.